| Samuel Yiu, MD | |
|
1450 San Pablo St, Suite 4000, Los Angeles, CA 90033-4668 | |
| (323) 442-6335 | |
| (323) 442-7166 |
| Full Name | Samuel Yiu |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 30 Years |
| Location | 1450 San Pablo St, Los Angeles, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043377286 | NPI | - | NPPES |
| D73528 | Other | MD | MD LICENSE |
| 180038361 | Other | CA | MEDICARE RAILROAD |
| 00A685410 | Medicaid | CA | |
| 00A685410 | Other | CA | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | A68541 (California) | Secondary |
| 207W00000X | Ophthalmology | D73528 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
"BMA Scotland supports the Scottish Government's aim to encourage a stronger sense of public ownership of the NHS and the renewed commitment to provide a service which is publicly funded and owned, free at the point of delivery. As such, we welcome the commitment to articulate the rights and responsibilities of all those using and providing NHS services.
Hemorrhagic fevers caused by Lassa, dengue and other viruses affect more than one million people annually and are often fatal, yet scientists have never understood why only some virus-infected people come down with the disease and others do not.
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
Contact lenses coated with an antimicrobial peptide could help to lower the risk of contact lens-related infections, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
› Verified 4 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
"BMA Scotland supports the Scottish Government's aim to encourage a stronger sense of public ownership of the NHS and the renewed commitment to provide a service which is publicly funded and owned, free at the point of delivery. As such, we welcome the commitment to articulate the rights and responsibilities of all those using and providing NHS services.
Hemorrhagic fevers caused by Lassa, dengue and other viruses affect more than one million people annually and are often fatal, yet scientists have never understood why only some virus-infected people come down with the disease and others do not.
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
Contact lenses coated with an antimicrobial peptide could help to lower the risk of contact lens-related infections, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Yiu, MD 6201 Greenleigh Ave, Middle River, MD 21220-2004 Ph: () - | Samuel Yiu, MD 1450 San Pablo St, Suite 4000, Los Angeles, CA 90033-4668 Ph: (323) 442-6335 |
News Archive
"BMA Scotland supports the Scottish Government's aim to encourage a stronger sense of public ownership of the NHS and the renewed commitment to provide a service which is publicly funded and owned, free at the point of delivery. As such, we welcome the commitment to articulate the rights and responsibilities of all those using and providing NHS services.
Hemorrhagic fevers caused by Lassa, dengue and other viruses affect more than one million people annually and are often fatal, yet scientists have never understood why only some virus-infected people come down with the disease and others do not.
Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).
Contact lenses coated with an antimicrobial peptide could help to lower the risk of contact lens-related infections, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
› Verified 4 days ago
Victoria Li-ting Tseng, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Stein Plaza #1-340, Los Angeles, CA 90095 Phone: 310-825-5000 | |
Peter Dentone, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 200 Stein Plaza #1-340, Los Angeles, CA 90095 Phone: 310-825-5000 | |
Kristin Elizabeth Nesburn, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8635 W 3rd Street, #390w, Los Angeles, CA 90048 Phone: 310-652-1133 Fax: 310-652-4353 | |
Dr. Stanley S. Kim, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3663 W 6th St, Suite #200, Los Angeles, CA 90020 Phone: 213-385-8500 Fax: 213-385-4896 | |
Homayoun Tabandeh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1245 Wilshire Blvd, 380, Los Angeles, CA 90017 Phone: 213-483-8810 Fax: 213-481-1503 | |
Arnold Barron, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 4733 W Sunset Blvd, Los Angeles, CA 90027 Phone: 323-783-4011 | |
Dr. Miguel Angel Unzueta, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1700 E Cesar E Chavez Ave, #3400, Los Angeles, CA 90033 Phone: 323-526-7273 Fax: 323-526-7235 |